5th European Headache and Migraine Trust Business

Our four day programme is built on basic and clinical science content. We will be covering the latest available research, therapies, and developments from internationally recognised leaders in the field. Our aim continues to be providing a better understanding of migraine, trigeminal autonomic cephalalgias, tension-type headache and other headache disorders. Participants will gather new scientific evidence and understanding that will improve diagnosis and treatment for patients.

Poster presentations will continue to be a key feature of EHMTIC 2016 and the programme has been planned to allow ample time for poster viewing and chaired discussions with an emphasis on interaction across all sessions. We will feature the best of our developing researchers in the New Scientist lectures, an opportunity to hear what is happening at the absolute cutting edge.

Teaching Courses are scheduled prior to the start of the main programme. They will include offerings focused updates for primary care practitioners and others with special interest in the field of headache; an educational case-based interactive session aimed at clinical staff to update their knowledge and learn about new therapies; and a course aimed at trainees interested in novel techniques and developments in migraine research.

We will finish with a public session for patients with migraine and headache disorders, providing an overview of the Congress presentations.

We are planning an invigorating programme and encourage you to attend all types of sessions to learn about the latest developments from our healthcare partners.

Join us in Glasgow for a memorable and inspiring event 15-18 September, 2016.

Url:

Inquiries: http://atnd.it/29613-1

Speakers: Peter Goadsby, Dimos Mitsikostas, Andrew Charles, Anne Ducros, Lars Edvinsson, Philip Holland, Arne May, Paolo Marteletti

More details